@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@slashgear.com 4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com 5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@xconomy.com 5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
@techcrunch.com 9 years ago
We Asked Rock Health Founder Halle Tecco About The Future Of Digital Medicine